Welcome to LookChem.com Sign In|Join Free
  • or
3-(oxetan-3-yloxy)propan-1-ol, also known as 3-(ethylene oxide)propan-1-ol, is a chemical compound with the molecular formula C6H12O3. It is a colorless liquid with a molecular weight of 132.16 g/mol. 3-(oxetan-3-yloxy)propan-1-ol is an ether derivative, featuring a propanol group (3-hydroxypropyl) attached to an oxetane (ethylene oxide) ring. It is commonly used as a solvent, surfactant, and intermediate in the synthesis of various chemicals, including pharmaceuticals and polymers. Due to its reactive nature, it can be involved in various chemical reactions, such as esterification and etherification. It is also known for its ability to form micelles in aqueous solutions, which makes it useful in applications requiring emulsification or stabilization.

1603017-74-8

Post Buying Request

1603017-74-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1603017-74-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1603017-74-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,0,3,0,1 and 7 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1603017-74:
(9*1)+(8*6)+(7*0)+(6*3)+(5*0)+(4*1)+(3*7)+(2*7)+(1*4)=118
118 % 10 = 8
So 1603017-74-8 is a valid CAS Registry Number.

1603017-74-8Upstream product

1603017-74-8Relevant academic research and scientific papers

Catalytic Enantioselective Synthesis of 1,4-Benzodioxepines

Zou, Xi,Sun, Guangwu,Huang, Hai,Wang, Jinping,Yang, Wen,Sun, Jianwei

, p. 249 - 252 (2020)

An efficient organocatalytic enantioselective synthesis of chiral 1,4-benzodioxepines is described. By proper incorporation of an intramolecular oxetane desymmetrization process, a range of benzylic alcohols bearing an internal oxetane reacted in the pres

THERAPEUTIC COMPOUNDS AND USES THEREOF

-

Paragraph 0434, (2014/09/03)

Described herein are compounds of Formula (I) or Formula (VI), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I) or Formula (VI) and pharmaceutical compositions thereof that are mucus penetrating. Methods of using the compounds or pharmaceutical compositions thereof for treating diseases are also provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1603017-74-8